Conflicting federal rulings led to latest U.S. Supreme Court decision on abortion pill mifepristone
Headline from UPI, on the newest of 3 developments
The U.S. Supreme Court issued an emergency ruling on Friday that allows continued access to the abortion pill mifepristone in states where abortion is legal.
UPI's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
The legal battle over abortion pills sits on the high court’s shadow docket as the justices decide the next move in the fight for access to reproductive health nationwide.
Groups challenging FDA approval of the abortion drug mifepristone say justices should preserve a lower court ruling that would bar people from obtaining it by mail.
A group of doctors opposed to abortion asked the Supreme Court Tuesday to restrict access to a key medication abortion drug while other legal challenges play out, as Wednesday night's deadline for the court to act approaches.
A federal appeals court ruled late Wednesday that mifepristone will retain its FDA approval and remain available but with more limitations on how the medication can be dispensed. For now, the ruling blocks the pill from being sent in the mail and shortens the length of time mifepristone can be used …
The Supreme Court has temporarily extended access to an abortion pill until Friday while the justices consider whether to allow restrictions on mifepristone to take effect as a legal challenge to the medication's FDA approval continues.
The Supreme Court is expected to issue an order on Wednesday in a case from Texas in which abortion opponents are seeking to roll back FDA approval of the drug, mifepristone.
Supreme Court justices are considering a request from the Biden administration and a New York-based drug company that manufactures the abortion drug mifepristone to delay lower-court rulings restricting its use.
The Supreme Court is slated to rule Wednesday on whether to allow a previous decision from an appeals court to take effect, which drastically limited access to a common abortion pill nationwide.
The Supreme Court on Wednesday issued an order extending a freeze on lower court orders that imposed restrictions on a widely used abortion pill in a case that tests the Food and Drug Administration's authority over drug approvals.
WEDNESDAY, April 19, 2023 (HealthDay News) – In the latest move to restrict access to the abortion pill mifepristone in the United States, a coalition of anti-abortion groups on Tuesday
WASHINGTON >> The Supreme Court has temporarily extended women’s access to an abortion pill until Friday while the justices consider whether to allow restrictions on mifepristone to take effect as a legal challenge to the medication’s Food and Drug Administration approval continues.
The Supreme Court is leaving women's access to a widely used abortion pill untouched until at least Friday, while the justices consider whether to allow restrictions on the drug mifepristone to take effect.
The company seeks an order preventing the FDA from taking mifepristone off the market if abortion opponents prevail in their fight to overturn the drug’s approval.
The Supreme Court has temporarily extended women's access to an abortion pill until Friday while the justices consider whether to allow restrictions on mifepristone to take effect as a legal challenge…
An administrative stay from the Supreme Court in a federal abortion pill case out of Texas expires late Wednesday, once again putting access to mifepristone in jeopardy.
By Ariane de Vogue, CNN Supreme Court Reporter Supreme Court Justice Samuel Alito on Wednesday temporarily extended a hold on a lower court ruling that would have imposed restrictions on access to an abortion drug, a move meant to give the justices more time to consider the issue.
The justices are considering whether to allow restrictions on mifepristone to take effect as a legal challenge to the medication's FDA approval continues.
The Supreme Court is deciding whether women will face restrictions in getting a drug used in the most common method of abortion in the U.S. while a lawsuit continues.
The Supreme Court is deciding whether women will face restrictions in getting a drug used in the most common method of abortion in the U.S. while a lawsuit continues.
The justices are still considering whether to allow restrictions on mifepristone to take effect while a legal challenge to the medication's FDA approval continues.
WASHINGTON — The Supreme Court should restrict the availability of the abortion pill mifepristone, anti-abortion-rights groups challenging the medication’s federal regulatory approval told the justices in a filing Tuesday, urging
